Abivax SA Sponsored ADR (2X10)
XSTU
Real-time Data
06:00 AM
Day's Range
77.0052 wk Range
61.50Overview - 2X10 - Abivax SA Sponsored ADR
Key Statistics
Valuation
Enterprise Value
5.98B
P/E (Trailing)
‪-16.56‬
PEG Ratio
‪0.62‬
Price / Sales (TTM)
‪1,495.35‬
Price / Book
‪17.39‬
EV / EBITDA
‪-20.52‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-8,617.93%‬
Return on Assets
‪-62.88%‬
Return on Equity
‪-252.34%‬
Ownership
Shares Outstanding
79.29M
Float
69.02M
Held by Insiders
‪0.00%‬
Held by Institutions
‪71.54%‬
Price stats
Beta
‪-0.24‬
50-Day Avg
‪102.18‬
200-Day Avg
‪101.97‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 2X10 - Abivax SA Sponsored ADR
Peers - 2X10 - Abivax SA Sponsored ADR
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- 2X10XSTUAbivax SA Sponsored ADR7.19BMarket Cap+12.50%52-week change-16.56P/E (Trailing)‪0.00%‬Profit Margin
- 6IBXSTUInnovent Biologics Inc.14.71BMarket Cap+6.26%52-week change—P/E (Trailing)‪86.53%‬Profit Margin
- 4KBXSTUKrystal Biotech, Inc.8.99BMarket Cap+52.99%52-week change43.02P/E (Trailing)‪54.81%‬Profit Margin
- 19XXSTUAxsome Therapeutics Inc.7.98BMarket Cap+41.36%52-week change-46.29P/E (Trailing)‪92.56%‬Profit Margin
- 30JXSTUIDEAYA Biosciences Inc.3.10BMarket Cap+29.17%52-week change-25.15P/E (Trailing)‪-74.75%‬Profit Margin
- BSFAXSTUAni Pharmaceuticals, Inc.1.49BMarket Cap-19.23%52-week change16.21P/E (Trailing)‪11.07%‬Profit Margin
- AN6XSTUAnaptysBio Inc.1.48BMarket Cap+55.76%52-week change-96.80P/E (Trailing)—Profit Margin
Profile Summary - 2X10 - Abivax SA Sponsored ADR
About
Abivax SA Sponsored ADR is a biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to help stabilize the immune response in chronic inflammatory diseases. The company’s lead program centers on obefazimod, a clinical-stage candidate being studied for inflammatory…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
